Piscitelli Dominic 4
4 · Oric Pharmaceuticals, Inc. · Filed Oct 8, 2025
Insider Transaction Report
Form 4
Piscitelli Dominic
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-10-06$14.52/sh−11,000$159,719→ 48,317 total - Exercise/Conversion
Common Stock
2025-10-06$4.36/sh+11,000$47,960→ 59,317 total - Exercise/Conversion
Stock Option (right to buy)
2025-10-06−11,000→ 196,500 totalExercise: $4.36From: 2025-07-20Exp: 2032-07-19→ Common Stock (11,000 underlying)
Footnotes (2)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2025.
- [F2]Represents the weighted average share price of an aggregate total of 11,000 shares sold in the price range of $14.50 to $14.53 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.